StockData
BlossomHill Therapeutics, Inc. logo

BlossomHill Therapeutics, Inc. (BLSM) company profile

BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$15.13+1.48 (+10.84%)

Close on Nov 17, 2026Market cap $38.56MP/E –Yield –

About BlossomHill Therapeutics

Pharmaceutical Preparations, SIC 2834

BlossomHill Therapeutics, Inc. is listed on Nasdaq under the ticker BLSM, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.

Company profile

Company

Legal name
BlossomHill Therapeutics, Inc.
Headquarters
San Diego, CA
Address
10255 Science Center Drive, Suite 200
Phone
(858) 732-3880
Industry
Pharmaceutical Preparations
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
BLSM
Exchange
Nasdaq
IPO date
Aug 7, 2026
Shares outstanding
32M, Sep 16, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1839970
CUSIP
095130100
ISIN
US0951301003
FIGI
BBG00ZHSKKM1
Share class FIGI
BBG00ZHSKKN0
EIN
85-1578711

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jingrong Jean CuiPresident and CEO, Director3,973,138
Yishan LiExecutive Chairman, Director3,859,703
Vincent Paul LiptakGeneral Counsel134,099
Jason A. KeyesChief Financial Officer700
Geoffrey Raymond OxnardChief Medical Officer17,785
Advisors Llc OrbimedDirector–
Capital GP VIII LLC OrbiMedDirector2,714,279
Carl L. GordonDirector2,714,279
John P. SchmidDirector6,000
Sundeep AgrawalDirector578,524
Bihua ChenDirector–
Sheila GujrathiDirector90,160

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Aug 7, 2026
Offer price
$16.00
Securities offered
9,375,000
Gross proceeds
$150.00M
Exchange
Nasdaq
Lock-up ends (est.)
Feb 3, 2027

“The initial public offering price is $16.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?